Tenaya Therapeutics

IPO

Scaling new heights in the fight against heart disease

Public · South San Francisco, United States · Founded 2016 · $198.0M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$198.0M
Last Round
$106.0M Series CMar 2021
Rounds
2
Type
Public

About

Tenaya Therapeutics is a clinical-stage biotechnology company founded by leading cardiovascular scientists to discover, design, develop and deliver potentially curative therapies that address the underlying drivers of heart disease. The company focuses on gene therapy and cellular reprogramming approaches to change the treatment paradigm for patients with serious cardiac conditions.

Summary

Tenaya Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $198.0M in total across 2 rounds, most recently a $106.0M Series C round in Mar 2021. Investors include Morgan Stanley, Cowen and Piper Sandler.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondaryDec 2025

Sign up to see all 4 rounds

Series B through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tenaya Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tenaya-therapeutics"><img src="https://indexed.vc/api/badge/company/tenaya-therapeutics" alt="Tenaya Therapeutics on Indexed.vc" width="260" height="76" /></a>